Xofluza 50242-0617-01

Generic: Baloxavir Marboxil

Package NDC

50242-0617-01

Manufacturer: Genentech, Inc.
Dosage Form: Granule, For Suspension
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: May 30, 2025
Listing Expires: December 31, 2026
Application: NDA214410

Need to source Xofluza? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Baloxavir Marboxil	40 mg/1

Drug Class

Chelating Activity [MoA]Polymerase Acidic Endonuclease Inhibitor [EPC]Polymerase Acidic Endonuclease Inhibitors [MoA]

Selected Package

50242-0617-01Selected

1 PACKET in 1 CARTON (50242-617-01) / 1 GRANULE, FOR SUSPENSION in 1 PACKET